These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17240107)

  • 61. A Retrospective Analysis of Anaerobic Bacteria Isolated in 236 Cases of Pleural Empyema and their Prevalance of Antimicrobial Resistance in Turkey.
    Demirci M; Gemicioglu B; Saribas S; Taner Z; Mamal-Torun M; Karatoka B; Asik-Cagli L; Guven O; Demiryas S; Kocazeybek BS; Bahar-Tokman H
    Clin Lab; 2018 Jul; 64(7):1269-1277. PubMed ID: 30146848
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis.
    Werner H; Heizmann WR; Höflsauer M
    Infection; 1991; 19(5):377-9. PubMed ID: 1800380
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Activity of doripenem against anaerobic bacteria].
    Dubreuil L; Neut C; Mahieux S; Muller-Serieys C; Jean-Pierre H; Marchandin H; Soussy CJ; Miara A
    Pathol Biol (Paris); 2011 Apr; 59(2):102-7. PubMed ID: 20537808
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro activity of ceftobiprole against Gram-positive and Gram-negative bacteria isolated from humans and animals.
    Silva N; Radhouani H; Gonçalves A; Araújo C; Rodrigues J; Igrejas G; Poeta P
    J Antimicrob Chemother; 2010 Apr; 65(4):801-3. PubMed ID: 20110342
    [No Abstract]   [Full Text] [Related]  

  • 65. Ceftobiprole: breaking therapeutic dogmas of the beta-lactam class.
    Deresinski SC
    Diagn Microbiol Infect Dis; 2008 May; 61(1):82-5. PubMed ID: 18384999
    [No Abstract]   [Full Text] [Related]  

  • 66. Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds.
    Goldstein EJ; Citron DM; Merriam CV; Tyrrell KL
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):347-51. PubMed ID: 23623385
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vitro activity of Bulgarian propolis against 94 clinical isolates of anaerobic bacteria.
    Boyanova L; Kolarov R; Gergova G; Mitov I
    Anaerobe; 2006 Aug; 12(4):173-7. PubMed ID: 16919977
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains.
    Sader HS; Fritsche TR; Kaniga K; Ge Y; Jones RN
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3501-12. PubMed ID: 16048970
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria.
    Genzel GH; Stubbings W; Stîngu CS; Labischinski H; Schaumann R
    Int J Antimicrob Agents; 2014 Nov; 44(5):420-3. PubMed ID: 25264128
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Activity of linezolid against anaerobic bacteria.
    Behra-Miellet J; Calvet L; Dubreuil L
    Int J Antimicrob Agents; 2003 Jul; 22(1):28-34. PubMed ID: 12842325
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods.
    Ednie LM; Credito KL; Khantipong M; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2000 May; 45(5):633-8. PubMed ID: 10797085
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chapter 3-3. Appendix: Drug-resistant anaerobes.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():162-4. PubMed ID: 21728116
    [No Abstract]   [Full Text] [Related]  

  • 73. In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species.
    Marchese A; Salerno A; Pesce A; Debbia EA; Schito GC
    Chemotherapy; 2000; 46(4):253-66. PubMed ID: 10859431
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole.
    Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 May; 41(5):1037-41. PubMed ID: 9145865
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams.
    Behra-Miellet J; Dubreuil L; Jumas-Bilak E
    Int J Antimicrob Agents; 2002 Nov; 20(5):366-74. PubMed ID: 12431872
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antimicrobial susceptibility patterns of clinically significant Gram-positive anaerobic bacteria in a Greek tertiary-care hospital, 2017-2019.
    Maraki S; Mavromanolaki VE; Stafylaki D; Kasimati A
    Anaerobe; 2020 Aug; 64():102245. PubMed ID: 32707228
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria.
    Citron DM; Merriam CV; Tyrrell KL; Warren YA; Fernandez H; Goldstein EJ
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2334-8. PubMed ID: 12821492
    [TBL] [Abstract][Full Text] [Related]  

  • 78. BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobials.
    Wootton M; Bowker KE; Holt HA; MacGowan AP
    J Antimicrob Chemother; 2002 Mar; 49(3):535-9. PubMed ID: 11864955
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Susceptibility of anaerobic bacteria to 23 antimicrobial agents.
    Sutter VL; Finegold SM
    Antimicrob Agents Chemother; 1976 Oct; 10(4):736-52. PubMed ID: 984809
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative in vitro activity of Ro 40-6890, Ro 41-3399, and other antimicrobial agents against anaerobic bacteria.
    Wüst J; Hardegger U
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):946-9. PubMed ID: 1486894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.